Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Egan

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 12, 2000
Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesiasG E Meredith, I E De Souza, T M Hyde, et al.
Schizophrenia Research|February 1, 1994
Event-related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophreniaM F Egan, C C Duncan, R L Suddath, et al.
Archives of General Psychiatry|September 15, 2000
Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellectT W Weickert, T E Goldberg, J M Gold, et al.
Brain Research|June 19, 1998
Effects of prefrontal cortical lesions on neuropeptide and dopamine receptor gene expression in the striatum-accumbens complexS M Baca, B K Lipska, M F Egan, et al.
Biological Psychiatry|January 1, 1994
Basal ganglia iron in tardive dyskinesia: an MRI studyA M Elkashef, M F Egan, J A Frank, et al.
Psychopharmacology|March 1, 1995
Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoateT M Hyde, M F Egan, L L Wing, et al.
Psychiatry Research|August 1, 1992
Cerebrospinal fluid and serum levels of neuron-specific enolase in patients with schizophreniaM F Egan, R S el-Mallakh, R L Suddath, et al.
Molecular Psychiatry|April 19, 2007
Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphismsY Sei, R Ren-Patterson, Z Li, et al.
Psychiatry Research|September 11, 1999
In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapineT J Raedler, M B Knable, T Lafargue, et al.
Biological Psychiatry|February 13, 2001
The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophreniaA Bertolino, J H Callicott, V S Mattay, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 12, 2000
Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesiasG E Meredith, I E De Souza, T M Hyde, et al.
Schizophrenia Research|February 1, 1994
Event-related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophreniaM F Egan, C C Duncan, R L Suddath, et al.
Archives of General Psychiatry|September 15, 2000
Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellectT W Weickert, T E Goldberg, J M Gold, et al.
Brain Research|June 19, 1998
Effects of prefrontal cortical lesions on neuropeptide and dopamine receptor gene expression in the striatum-accumbens complexS M Baca, B K Lipska, M F Egan, et al.
Biological Psychiatry|January 1, 1994
Basal ganglia iron in tardive dyskinesia: an MRI studyA M Elkashef, M F Egan, J A Frank, et al.
Psychopharmacology|March 1, 1995
Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoateT M Hyde, M F Egan, L L Wing, et al.
Psychiatry Research|August 1, 1992
Cerebrospinal fluid and serum levels of neuron-specific enolase in patients with schizophreniaM F Egan, R S el-Mallakh, R L Suddath, et al.
Molecular Psychiatry|April 19, 2007
Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphismsY Sei, R Ren-Patterson, Z Li, et al.
Psychiatry Research|September 11, 1999
In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapineT J Raedler, M B Knable, T Lafargue, et al.
Biological Psychiatry|February 13, 2001
The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophreniaA Bertolino, J H Callicott, V S Mattay, et al.
Pageof 7